找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Alternative Approaches to Human Blood Resources in Clinical Practice; Proceedings of the T C. Th. Smit Sibinga,P. C. Das,J. C. Fratantoni C

[复制链接]
楼主: mortality
发表于 2025-3-25 04:40:02 | 显示全部楼层
https://doi.org/10.1007/978-3-662-06599-0 a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice [1–4].
发表于 2025-3-25 10:31:06 | 显示全部楼层
发表于 2025-3-25 11:41:29 | 显示全部楼层
Die Kollapstherapie der Lungentuberkulose,(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
发表于 2025-3-25 16:59:17 | 显示全部楼层
The Role of O2 Transport in the Development of the Transfusion Trigger(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
发表于 2025-3-25 20:39:53 | 显示全部楼层
发表于 2025-3-26 00:46:28 | 显示全部楼层
Evidence-Based Transfusion Medicine or the Need to Evaluate Clinical Outcome a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice [1–4].
发表于 2025-3-26 04:44:57 | 显示全部楼层
The Development of Synthocytes™, a Novel Platelet Substituteet transfusion include a reduced risk of blood borne virus transmission, no risk of alloimmunogenic reactions, an increased shelf life and therefore a more cost effective, more easily managed therapy.
发表于 2025-3-26 09:09:57 | 显示全部楼层
Conference proceedings 1998development of alternative approaches in thisrapidly developing area. In clinical medicine conventional blood andits components are used in supportive therapies dependent on thechoice of apparent uncritical trigger factors. A compounding factor isdepth of prospective clinical trials for evidence. Su
发表于 2025-3-26 15:59:38 | 显示全部楼层
发表于 2025-3-26 17:08:21 | 显示全部楼层
Warum es diese Patientenleitlinie gibt,perative haemoglobin level or platelet transfusion level, the preferences of opinion leaders in the local clinical community [7], the availability of a transfusion committee with an authoritative surveillance system, variations in supply or in local or regional risks or public perceptions of those risks.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-10 08:26
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表